MedPath

Prospective, randomized, double-blind, parallel, placebo-controlled, multicenter clinical studies of acupuncture point patches for the treatment of Hashimoto's thyroiditis

Not Applicable
Not yet recruiting
Conditions
Hashimoto's thyroiditis
Registration Number
ITMCTR2200005620
Lead Sponsor
The Affiliated Hospital of Shandong University of TCM
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Female
Target Recruitment
Not specified
Inclusion Criteria

1. Those who meet the diagnostic criteria of Hashimoto thyroiditis and Western medicine;
2. Young women aged 18 to 45;
3. Laboratory tests of thyroid function show that TPOAb (normal value: 0~34IU/ml) and TgAb (normal value: 0~115IU/mL) are elevated, while FT3 (normal value: 3.1~6.8pmol/L), FT4 (normal value: 12~22pmol/L) and TSH (normal value: 0.270~4.20mIU/L) levels are normal;
4. Informed consent and signing of informed consent.

Exclusion Criteria

1. Exclude thyroid cancer and thyroid surgery;
2. The clinical data and related examination results are incomplete;
3. Those who have their own original diabetes, hyperlipidemia and other metabolic diseases;
4. Those who need conventional medication treatment with other diseases;
5. Those who have skin trauma, ulcers, infections or scars at the patch site and are allergic to the patch;
6. Other factors can not cooperate with the investigator.
Note: Any one or more of the above items should be excluded and cannot be selected.

Study & Design

Study Type
Interventional study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.